High D-dimer level at presentation in patients with venous thrombosis is a marker for malignancy.
Shankaranarayana Paneesha(Warwick Hospital), Peter Rose(Academy of Nutrition and Dietetics), Å. Borg(Warwick Hospital), Julio Delgado(Departament de Salut), Elizabeth Cheyne(University Hospital Coventry), K. French(University Hospital Coventry)
PubMed
December 1, 2005
Cited by 6
Related Papers
Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia
|New England Journal of Medicine|2014|1.6k
Hydrogen Sulfide and Cell Signaling
|The Annual Review of Pharmacology and Toxicology|2011|1.3k
Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies
|British Journal of Haematology|2012|867
Non-coding recurrent mutations in chronic lymphocytic leukaemia
|Nature|2015|851
Bioactive S-alk(en)yl cysteine sulfoxide metabolites in the genus Allium: the chemistry of potential therapeutic agents
|Natural Product Reports|2005|469